α-galactosylceramide, a ligand of natural killer T cells, inhibits allergic airway inflammation

American Journal of Respiratory Cell and Molecular Biology

Volumn 33, Issue 1, 2005, Pages 22-31

  Matsuda, Hiroyuki ^a   Suda, Takafumi ^a   Sato, Jun ^a   Nagata, Toshi ^a   Koide, Yukio ^a   Chida, Kingo ^a   Nakamura, Hirotoshi ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

galactosylceramide; Asthma; Interferon ; Natural killer T cell

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; GAMMA INTERFERON; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G2A; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; LIGAND; METHACHOLINE; OVALBUMIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTHMA; CELL ACTIVATION; CELL HYPERPLASIA; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; FEMALE; GOBLET CELL; IN VIVO STUDY; KNOCKOUT MOUSE; LUNG LAVAGE; MOUSE; NATURAL KILLER CELL; NONHUMAN; RESPIRATORY TRACT ALLERGY; RESPIRATORY TRACT INFLAMMATION;

ANIMALS; ANTIGENS; ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; CYTOTOXICITY, IMMUNOLOGIC; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; GALACTOSYLCERAMIDES; GOBLET CELLS; HYPERPLASIA; HYPERSENSITIVITY; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INFLAMMATION; INTERFERON TYPE II; KILLER CELLS, NATURAL; LIGANDS; LUNG; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; OVALBUMIN; T-LYMPHOCYTES; TH2 CELLS; TIME FACTORS;

ANIMALIA;

EID: 21844476225     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2004-0010OC     Document Type: Article

References (45)

1. Wills-Karp M. Immunologic basis of antigen-induced airway hyperresponsiveness. Annu Rev Immunol 1999;17:255-281.
2. Robinson DS, Hamid Q, Ying S, Tsicopoulos A, Barkans J, Bentley AM, Corrigan C, Durham SR, Kay AB. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992;326:298-304.
3. + T cells, increased TH2-type cytokine mRNA expression, and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthma. J Allergy Clin Immunol 1993;92:313-324.
4. Seminario MC, Gleich GJ. The role of eosinophils in the pathogenesis of asthma. Curr Opin Immunol 1994;6:860-864.
5. Busse WW, Lemanske RF Jr. Asthma. N Engl J Med 2001;344:350-362.
6. Cohn L, Tepper JS, Bottomly K. IL-4-independent induction of airway hyperresponsiveness by Th2, but not Th1, cells. J Immunol 1998;161:3813-3816.
7. Cohn L, Homer RJ, Marinov A, Rankin J, Bottomly K. Induction of airway mucus production by T helper 2 (Th2) cells: a critical role for interleukin 4 in cell recruitment but not mucus production. J Exp Med 1997;186:1737-1747.
8. Hogan SP, Matthaei KI, Young JM, Koskinen A, Young IG, Foster PS. A novel T cell-regulated mechanism modulating allergen-induced airways hyperreactivity in BALB/c mice independently of IL-4 and IL-5. J Immunol 1998;161:1501-1509.
9. Nakajima H, Iwamoto I, Yoshida S. Aerosolized recombinant interferon-γ prevents antigen-induced eosinophil recruitment in mouse trachea. Am Rev Respir Dis 1993;148:1102-1104.
10. + T cells. J Exp Med 1993:177:573-576.
11. Bendelac A, Rivera MN, Park SH, Roark JH. Mouse CD1-specific NK1 T cells: development, specificity, and function. Anna Rev Immunol 1997;15:535-562.
12. Godfrey DI, Hammond KJ, Poulton LD, Smyth MJ, Baxter AG. NKT cells: facts, functions and fallacies. Immunol Today 2000;21:573-583.
13. Kronenberg M, Gapin L. The unconventional lifestyle of NKT cells. Nat Rev Immunol 2002;2:557-568.
14. - T cells in mice and humans. J Exp Med 1994;180:1097-1106.
15. - α/β T cells demonstrates preferential use of several V β genes and an invariant TCR α chain. J Exp Med 1993;178:1-16.
16. - subset. J Exp Med 1993;177:1763-1771.
17. + T lymphocytes. Science 1995;268:863-865.
18. Kawano T, Cui J, Koezuka Y, Toura I, Kaneko Y, Motoki K, Ueno H, Nakagawa R, Sato H, Kondo E, et al. CD1d-restricted and TCR-mediated activation of Vα14 NKT cells by glycosylceramides. Science 1997;278:1626-1629.
19. + NK T lymphocytes. J Immunol 1998;161:3271-3281.
20. Jahng AW, Maricic I, Pedersen B, Burdin N, Naidenko O, Kronenberg M, Koezuka Y, Kumar V. Activation of natural killer T cells potentiates or prevents experimental autoimmune encephalomyelitis. J Exp Med 2001;194:1789-1799.
21. Sharif S, Arreaza GA, Zucker P, Mi QS, Sondhi J, Naidenko OV, Kronenberg M, Koezuka Y, Delovitch TL, Gombert JM, et al. Activation of natural killer T cells by α-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes. Nat Med 2001;7:1057-1062.
22. Hong S, Wilson MT, Serizawa I, Wu L, Singh N, Naidenko OV, Miura T, Haba T, Scherer DC, Wei J, et al. The natural killer T-cell ligand α-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice. Nat Med 2001;7:1052-1056.
23. Cui J, Watanabe N, Kawano T, Yamashita M, Kamata T, Shimizu C, Kimura M, Shimizu E, Koike J, Koseki H, et al. Inhibition of T helper cell type 2 cell differentiation and immunoglobulin E response by liaand-activated Vα14 natural killer T cells. J Exp Med 1999;190:783-792.
24. + natural killer T cells by α-galactosylceramide results in development of Th1 response and local host resistance in mice infected with Cryptococcus neoformans. Infect Immun 2001;69:213-220.
25. Akbari O, Stock P, Meyer E, Kronenberg M, Sidobre S, Nakayama T, Taniguchi M, Grusby MJ, DeKruyff RH, Umetsu DT. Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity. Nat Med 2003;9:582-588.
26. Lisbonne M, Diem S, de Castro Keller A, Lefort J, Araujo LM, Hachem P, Fourneau JM, Sidobre S, Kronenberg M, Taniguchi M, et al. Cutting edge: invariant Vα 14 NKT cells are required for allergen-induced airway inflammation and hyperreactivity in an experimental asthma model. J Immunol 2003;171:1637-1641.
27. Russo M, Nahori MA, Lefort J, Gomes E, de Castro Keller A, Rodriguez D, Ribeiro OG, Adriouch S, Gallois V, de Faria AM, et al. Suppression of asthma-like responses in different mouse strains by oral tolerance. Am J Respir Cell Mol Biol 2001;24:518-526.
28. Kitamura H, Iwakabe K, Yahata T, Nishimura S, Ohta A, Ohmi Y, Sato M, Takeda K, Okumura K, Van Kaer L, et al. The natural killer T (NKT) cell ligand α-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells. J Exp Med 1999;189:1121-1128.
29. +NKT cells: stimulation of IL-12 production by antigen-presenting cells in the innate immune system. J Immunol 1999;163:93-101.
30. Fahy JV. Goblet cell and mucin gene abnormalities in asthma. Chest 2002;122:320S-326S.
31. Henderson WR Jr, Lewis DB, Albert RK, Zhang Y, Lamm WJ, Chiang GK, Jones F, Eriksen P, Tien YT, Jonas M, et al. The importance of leukotrienes in airway inflammation in a mouse model of asthma. J Exp Med 1996;184:1483-1494.
32. Zuhdi Alimam M, Piazza FM, Selby DM, Letwin N, Huang L, Rose MC. Muc-5/5ac mucin messenger RNA and protein expression is a marker of goblet cell metaplasia in murine airways. Am J Respir Cell Mol Biol 2000;22:253-260.
33. Coffman RL, Lebman DA, Rothman P. Mechanism and regulation of immunoglobulin isotype switching. Adv Immunol 1993;54:229-270.
34. +T cells and natural killer cells is essential for the antimetastatic effect of α-galactosylceramide. Blood 2002;99:1259-1266.
35. Gonzalez-Aseguinolaza G, de Oliveira C, Tomaska M, Hong S, Bruna-Romero O, Nakayama T, Taniguchi M, Bendelac A, Van Kaer L, Koezuka Y, et al. α-galactosylceramide-activated Vα14 natural killer T cells mediate protection against murine malaria. Proc Natl Acad Sci USA 2000;97:8461-8466.
36. Duthie MS, Kahn SJ. Treatment with α-galactosylceramide before Trypanosoma cruzi infection provides protection or induces failure to thrive. J Immunol 2002;168:5778-5785.
37. Hofstra CL, Van Ark I, Hofman G, Nijkamp FP, Jardieu PM, Van Oosterhout AJ. Differential effects of endogenous and exogenous interferon-γ on immunoglobulin E, cellular infiltration, and airway responsiveness in a murine model of allergic asthma. Am J Respir Cell Mol Biol 1998;19:826-835.
38. Dalton DK, Pitts-Meek S, Keshav S, Figari IS, Bradley A, Stewart TA. Multiple defects of immune cell function in mice with disrupted interferon-γ genes. Science 1993;259:1739-1742.
39. Rodriguez D, Keller AC, Faquim-Mauro EL, de Macedo MS, Cunha FQ, Lefort J, Vargaftig BB, Russo M. Bacterial lipopolysaccharide signaling through Toll-like receptor 4 suppresses asthma-like responses via nitric oxide synthase 2 activity. J Immunol 2003;171:1001-1008.
40. H1 cytokines to prevent eosinophilic airway inflammation in a murine model of asthma. J Allergy Clin Immunol 1999;104:1258-1264.
41. H2 bias of natural killer T cells. Nature 2001;413:531-534.
42. Zhang Y, Rogers KH, Lewis DB. β2-microglobulin-dependent T cells are dispensable for allergen-induced T helper 2 responses. J Exp Med 1996;184:1507-1512.
43. Kips JC, Brusselle GJ, Joos GF, Peleman RA, Tavernier JH, Devos RR, Pauwels RA. Interleukin-12 inhibits antigen-induced airway hyperresponsiveness in mice. Am J Respir Crit Care Med 1996;153:535-539.
44. Bryan SA, O'Connor BJ, Matti S, Leckie MJ, Kanabar V, Khan J, Warrington SJ, Renzetti L, Rames A, Bock J A, et al. Effects of recombinant human interleukin-12 on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 2000;356:2149-2153.
45. Giaccone G, Punt CJ, Ando Y, Ruijter R, Nishi N, Peters M, von Blomberg BM, Scheper RJ, van der Vliet HJ, van den Eertwegh AJ, et al. A phase I study of the natural killer T-cell ligand alpha-galactosylceramide (KRN7000) in patients with solid tumors. Clin Cancer Res 2002;8:3702-3709.